Development of novel tetrahydroisoquinoline-hydroxamate conjugates as potent dual SERDs/HDAC inhibitors for the treatment of breast cancer
- Resource Type
- Article
- Source
- In
European Journal of Medicinal Chemistry 15 December 2021 226 - Subject
- Language
- ISSN
- 0223-5234